FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:53-54 July 7, 1994 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Jensen, D. M. PubMed Citation

To the Editor: Jensen et al. (Feb. 10 issue)¹ showed that recurrent bleeding of duodenal ulcers can be prevented to a large extent by instituting maintenance therapy with histamine H-receptor blockers. Since the authors excluded all patients who were using ulcerogenic drugs, it is likely that almost all the patients had helicobacter-associated duodenal ulcers. Unfortunately, the developments in research on Helicobacter pylori already outdate the results and conclusions of this study.

There is overwhelming scientific evidence that H. pylori is the most important factor in duodenal ulcer disease, especially with respect to relapse². After successful eradication with triple therapy . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.